Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.42 |
| ▸ | KLK5 | Q9Y337 | 4/20 | 0.42 |
| ▸ | KLK7 | P49862 | 4/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063867 | 1.00 | ABCB1 (0.46) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL3059318 | 0.94 | ABCB1 (0.47) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL3059316 | 0.94 | ABCB1 (0.47) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL7806323 | 0.89 | ABCB1 (0.43) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL14206129 | 0.89 | ABCB1 (0.43) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL12401301 | 0.83 | HDAC1 (0.37) | ITGB3ITGA2BCTSK | |
| SCHEMBL3043829 | 0.83 | ABCB1 (0.41) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL3043831 | 0.83 | ABCB1 (0.41) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL4955779 | 0.83 | ABCB1 (0.41) | ABCB1ITGB3ITGA2BKLK5KLK7 | |
| SCHEMBL29992065 | 0.82 | TGM2 (0.39) | ITGB3ITGA2BKLK5CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089385-A2 | INHIBITORS OF HEPATITIS C VIRUS | Brystol-Myers Squibb Company (US) | 2009-08-19 | — | — | EP | disclosed |
| EP-2086994-A2 | INHIBITORS OF HEPATITIS C VIRUS | Brystol-Myers Squibb Company (US) | 2009-08-12 | — | — | EP | disclosed |
| EP-2086967-A2 | INHIBITORS OF HEPATITIS C VIRUS | Brystol-Myers Squibb Company (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008057871-A2 | INHIBITORS OF HEPATITIS C VIRUS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-15 | — | — | WO | disclosed |
| WO-2008057873-A2 | INHIBITORS OF HEPATITIS C VIRUS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-15 | — | — | WO | disclosed |
| WO-2008057875-A2 | INHIBITORS OF HEPATITIS C VIRUS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-15 | — | — | WO | disclosed |